Recombinant Synechococcus sp. Apolipoprotein N-acyltransferase (lnt) is a recombinant protein derived from the cyanobacterium Synechococcus sp. This enzyme plays a crucial role in the maturation of lipoproteins by catalyzing the N-acylation of the N-terminal cysteine residue. The recombinant form of this enzyme is typically expressed in Escherichia coli and is used for research purposes.
Species: Synechococcus sp.
Source: Expressed in E. coli.
Tag: N-terminal His tag.
Protein Length: Full-length, spanning 1-465 amino acids.
Form: Lyophilized powder.
Purity: Greater than 90% as determined by SDS-PAGE.
Storage: Store at -20°C or -80°C upon receipt. Avoid repeated freeze-thaw cycles.
| Specification | Description |
|---|---|
| Species | Synechococcus sp. |
| Source | E. coli |
| Tag | N-terminal His tag |
| Protein Length | Full-length (1-465aa) |
| Form | Lyophilized powder |
| Purity | >90% by SDS-PAGE |
| Storage | -20°C or -80°C |
Apolipoprotein N-acyltransferase (lnt) belongs to the nitrilase superfamily and catalyzes the attachment of a fatty acid to the alpha-amino group of the N-terminal cysteine of apolipoproteins. This process occurs through a two-step ping-pong mechanism, where the first step involves the acyl transfer from a phospholipid substrate to form a thioester linkage on the active site cysteine. The second step involves the transfer of the acyl chain from this cysteine to the N-terminal cysteine of the apolipoprotein, resulting in the final mature lipoprotein .
Recombinant Synechococcus sp. Apolipoprotein N-acyltransferase (lnt) is used in research to study lipoprotein maturation and its implications in bacterial physiology. Understanding the mechanisms of lnt can provide insights into bacterial virulence and potential therapeutic targets. Additionally, the enzyme's role in lipid modification makes it relevant for studies on bacterial membrane structure and function.
KEGG: syw:SYNW1623
STRING: 84588.SYNW1623
Apolipoprotein N-acyltransferase (Lnt) is an integral membrane protein that catalyzes the final step in post-translational modification of bacterial lipoproteins. Its primary function involves transferring an acyl chain from a phospholipid to the α-amino group of the N-terminal diacylglyceryl-modified cysteine of apolipoprotein, resulting in a mature triacylated lipoprotein . The enzyme undergoes a two-step reaction mechanism: first forming a thioester acyl-enzyme intermediate with the phospholipid donor, then transferring this acyl group to the apolipoprotein substrate . This modification is essential for proper lipoprotein function in bacterial cell envelopes.
Synechococcus sp., particularly Synechococcus elongatus PCC 7942, offers several advantages as an expression system for recombinant proteins, including membrane proteins like Lnt:
It possesses a small genome (2.7 Mb) that is easily manipulated through natural transformation .
The system enables high-level protein expression, with recombinant proteins representing >10% of total soluble protein using optimized vectors .
It allows targeted integration of genes into the genome with >80% integration efficiency .
The organism can be cultivated in simple media like BG-11 with minimal requirements .
Modern Synechococcus strains demonstrate high compatibility with advanced genetic tools like CRISPR-Cas12a, with single insertion efficiencies of 31-81% .
As a photosynthetic organism, it offers economic advantages for large-scale protein production.
Working with recombinant Lnt in Synechococcus sp. presents several key differences compared to studying the native enzyme:
Membrane environment differences: Lnt activity is strongly affected by phospholipid headgroup and acyl chain composition . Synechococcus membranes have a different composition than those of bacteria where Lnt naturally functions.
Expression optimization challenges: Membrane protein overexpression can cause toxicity and improper folding, requiring careful optimization of expression conditions.
Purification considerations: Extracting recombinant Lnt while maintaining its native conformation requires specialized detergents and techniques that differ from those used with native Lnt.
Activity assessment: Kinetic parameters and substrate preferences may differ between native and recombinant Lnt due to the expression environment, necessitating careful comparative studies.
Post-translational modifications: Potential differences in post-translational modifications between host systems may affect enzymatic function.
An optimized expression system for recombinant Lnt in Synechococcus sp. should include the following components:
Vector design:
Utilize a strong constitutive promoter such as psbA1 for robust expression
Incorporate an optimized ribosome binding site (RBS) to enhance translation efficiency
Include purification tags such as N-terminal 6His-TEV and/or C-terminal V5-His epitope tags
Target integration into validated neutral sites to prevent disruption of essential functions
Selection strategy:
Implement spectinomycin resistance (25 μg/mL) as the preferred selection marker, as Synechococcus shows robust susceptibility to this antibiotic
Consider alternative markers if needed: kanamycin (100 μg/mL), gentamicin (50 μg/mL), erythromycin (1.25 μg/mL), or chloramphenicol (5 μg/mL)
Integration approach:
Use natural transformation for genomic integration with expectation of >80% integration efficiency
For membrane proteins like Lnt, consider lower expression temperatures to improve proper folding
If initial expression attempts show toxicity, implement inducible systems like the DAPG-inducible PhlF repressor system
Purifying active recombinant Lnt from Synechococcus sp. requires a specialized approach due to its membrane-embedded nature:
Membrane preparation:
Harvest Synechococcus cells expressing recombinant Lnt (typically 3-5 days post-transformation)
Disrupt cells using methods compatible with cyanobacteria (sonication or bead-beating)
Isolate membrane fractions through differential centrifugation
Wash membranes to remove peripheral proteins
Membrane protein solubilization:
Solubilize membranes using mild detergents (n-dodecyl-β-D-maltoside or digitonin)
Maintain phospholipids in the solubilization buffer, as they affect Lnt activity
Remove insoluble material by high-speed centrifugation
Affinity purification:
Utilize the N-terminal 6His-TEV tag for initial capture on Ni-NTA resin
Include appropriate detergent in all buffers to maintain protein solubility
Elute using imidazole gradient (50-300 mM)
If higher purity is required, use the C-terminal V5-His tag for secondary purification
Activity preservation:
Include phosphatidylethanolamine in purification buffers, as it serves as a preferred acyl donor
Consider reconstitution into liposomes or nanodiscs for activity studies
Store with glycerol (10%) and reducing agent to preserve the catalytic cysteine
Based on published methodologies, a robust mixed micelle assay can effectively measure recombinant Lnt activity :
Assay components:
Purified recombinant Lnt (typically 0.1-1 μM)
Phospholipid acyl donors (preferably phosphatidylethanolamine)
Synthetic diacylglyceryl-modified lipopeptide substrate (e.g., FSL-1)
Detergent system (Triton X-100 or similar)
Buffer system (pH 7.4-8.0)
Reaction setup:
Prepare mixed micelles containing phospholipids and detergent
Add purified Lnt enzyme
Initiate reaction by adding the lipopeptide substrate
Incubate at 30°C for defined time periods
Detection methods:
Radiochemical detection: Use [(3)H]palmitate-labeled phospholipids and measure incorporation into the lipopeptide substrate
Mass spectrometry: Analyze reaction products by LC-MS/MS to detect acylated products
HPLC analysis: Separate and quantify reaction products based on hydrophobicity changes
Kinetic analysis:
Determine initial velocities at varying substrate concentrations
Calculate Km and Vmax values for both the phospholipid donor and lipopeptide substrate
When characterizing recombinant Lnt, the following controls are essential to ensure reliable and interpretable results:
Expression and purification controls:
Western blot analysis with anti-His or anti-V5 antibodies to confirm expression and size
Empty vector control to validate specificity of detection
Membrane fractionation to confirm proper localization
Size exclusion chromatography to assess oligomeric state and homogeneity
Activity assay controls:
Catalytic cysteine mutant (C→A/S) to confirm thioester mechanism
Heat-inactivated enzyme control to verify enzyme-dependent activity
No-enzyme and no-substrate controls to establish baseline
Time-course sampling to ensure measurements in the linear range
Enzyme concentration series to confirm proportional activity
Substrate specificity controls:
Various phospholipid donors to confirm headgroup preferences
Different lipopeptide substrates to assess substrate recognition
Competition assays to verify specific binding
Data validation:
Multiple independent protein preparations to ensure reproducibility
Alternative assay methods to confirm results (e.g., radiolabeling and mass spectrometry)
Positive control with a known Lnt enzyme (e.g., from E. coli) when possible
The phospholipid environment critically influences Lnt activity, with significant implications for recombinant expression:
Headgroup specificity:
Studies have demonstrated that "N-acyltransferase activity was strongly affected by the phospholipid headgroup and acyl chain composition" . This presents a challenge for recombinant expression in Synechococcus sp., whose membrane composition differs from bacteria where Lnt naturally occurs.
Acyl chain preferences:
Lnt demonstrates preferences for specific acyl chain lengths and saturation levels as donors for the acylation reaction. The natural phospholipid composition of Synechococcus membranes may provide suboptimal acyl donors, potentially affecting enzymatic efficiency.
Experimental approaches to address this issue:
| Approach | Methodology | Expected Outcome |
|---|---|---|
| Phospholipid profiling | Lipidomics analysis of Synechococcus membranes vs. native Lnt host | Identification of compositional differences |
| Donor screening | Test activity with various purified phospholipids | Determination of optimal acyl donors |
| Membrane engineering | Express phospholipid synthesis enzymes to modify composition | Creation of more favorable lipid environment |
| Reconstitution studies | Compare activity in different membrane mimetic systems | Optimization of in vitro reaction conditions |
This understanding is crucial for accurate comparison between native and recombinant Lnt and for optimizing expression systems.
CRISPR-Cas12a offers powerful approaches for optimizing Lnt expression in Synechococcus sp., with several strategic applications:
Precise genomic integration:
Synechococcus sp. strains show high efficiency with CRISPR-Cas12a genome editing (31-81% for single insertions) . This precision can be used to integrate the lnt gene at optimal genomic locations that balance expression with minimal physiological disruption.
Promoter optimization:
CRISPR-Cas12a can facilitate the testing of various promoters:
Inducible systems like the DAPG-inducible PhlF repressor system
Creation of promoter libraries to identify optimal expression levels
Genetic circuit engineering:
Implement multiplex editing (demonstrated efficiency of 25%) to simultaneously modify multiple genomic targets
Create Lnt variants with modified membrane-association domains
Engineer markerless mutations using the CRISPR-Cas12a approach described by Mills et al.
Host optimization:
Modify pathways affecting membrane phospholipid composition to create a more favorable environment for Lnt activity
Engineering reduced protease activity to improve recombinant protein stability
Modify cell wall characteristics to facilitate protein extraction
These strategies can be implemented using the modular method for generating markerless mutants described in the literature , providing precise control over Lnt expression and activity.
Comparing the catalytic mechanisms of native versus recombinant Lnt reveals important insights about the influence of expression systems on enzyme function:
Reaction mechanism comparison:
Both native and recombinant Lnt follow a ping-pong type mechanism involving:
Formation of a thioester acyl-enzyme intermediate (slow step)
Transfer of the acyl group to the apolipoprotein substrate (fast step)
Key kinetic parameters to compare:
Structural considerations:
Potential differences in membrane topology between expression systems
Altered protein dynamics in different membrane environments
Impact of purification tags on enzyme conformation and substrate access
Understanding these differences is crucial for interpreting experimental results and optimizing recombinant Lnt production.
Strategic structural engineering can significantly enhance recombinant Lnt functionality:
Targeted modifications:
Membrane association optimization:
Modify transmembrane domains to better match Synechococcus membrane thickness
Engineer improved phospholipid interaction sites based on headgroup availability
Adjust hydrophobic mismatch at membrane interfaces
Catalytic site engineering:
Stability enhancements:
Introduce disulfide bonds away from the active site to stabilize tertiary structure
Modify surface charges to improve solubility while maintaining membrane association
Engineer salt bridges to stabilize critical domains
Flexible linker design:
Implementation approach:
Utilize computational modeling to predict effective modifications
Create a library of variants with different modifications
Screen for expression level, stability, and activity
Combine beneficial modifications to create optimized variants
Verify that modifications don't disrupt the ping-pong mechanism
The dual-tagging system (N-terminal 6His-TEV and C-terminal V5-His) available in the Synechococcus expression system provides flexibility for implementing and testing these modifications .
Researchers frequently encounter several challenges when expressing active recombinant Lnt:
Expression-related challenges:
Toxicity: Overexpression of membrane proteins can disrupt host membrane integrity
Incomplete segregation: Obtaining fully segregated transformants can be difficult
Incorrect localization: Improper membrane targeting or insertion
Solution: Verify membrane fraction localization through western blotting
Solution: Consider adding native signal sequences if absent
Activity-related challenges:
Phospholipid environment incompatibility: Lnt activity is strongly affected by phospholipid composition
Solution: Supplement with preferred phospholipids during activity assays
Solution: Consider membrane engineering approaches
Improper folding: Despite expression, protein may not fold correctly
Solution: Test multiple detergents for solubilization
Solution: Employ chaperone co-expression strategies
Catalytic residue modification: The crucial thioester-forming cysteine may be modified
Solution: Include reducing agents in purification buffers
Solution: Verify thioester formation capability using mass spectrometry
Detection challenges:
Low signal-to-noise ratio in activity assays
Distinguishing enzyme-catalyzed from non-enzymatic acyl transfer
Solution: Include catalytic mutant controls
Solution: Perform detailed kinetic analysis demonstrating enzyme dependence
When facing contradictory substrate specificity data, a systematic investigative approach is necessary:
Sources of contradictory data:
Different assay systems (in vivo vs. in vitro, different detection methods)
Variations in protein preparation (expression conditions, purification methods)
Substrate variations (purity, presentation method)
Systematic investigation framework:
Standardize methodology:
Control for protein quality:
Verify protein folding and homogeneity before experiments
Use fresh protein preparations to minimize degradation effects
Quantify active enzyme concentration through active site titration
Examine substrate factors:
Verify substrate purity through analytical methods
Test substrate concentration dependencies
Compare different substrate presentation methods (micelles vs. liposomes)
Data analysis matrix:
| Variable | Condition 1 | Condition 2 | Condition 3 | Interpretation |
|---|---|---|---|---|
| Phospholipid composition | PE-rich | PC-rich | PG-rich | Determines headgroup preference |
| Detergent system | Triton X-100 | DDM | Digitonin | Affects enzyme conformation |
| Substrate concentration | 1-10 μM | 10-100 μM | 100-1000 μM | Reveals concentration dependencies |
| pH | 6.5 | 7.5 | 8.5 | Identifies optimal conditions |
| Temperature | 25°C | 30°C | 37°C | Determines thermal preferences |
Model development:
Look for patterns explaining contradictions
Consider whether differences reflect distinct enzyme conformations
Develop a comprehensive model accommodating seemingly contradictory observations
This systematic approach can transform contradictory data into deeper mechanistic understanding of enzyme behavior.
Assessing proper folding and catalytic competence of recombinant Lnt requires a multi-faceted approach:
Structural integrity assessment:
Size exclusion chromatography to verify monodispersity and appropriate oligomeric state
Circular dichroism spectroscopy to confirm secondary structure content
Limited proteolysis to probe tertiary structure (properly folded membrane proteins show characteristic resistance patterns)
Thermal stability assays to determine melting temperature and stability
Membrane integration verification:
Membrane fractionation to confirm localization in membrane fractions
Protease protection assays to determine proper topology
Detergent extraction profiles to verify characteristic membrane protein behavior
Functional verification hierarchy:
Phospholipid binding: Verify interaction with phospholipids using fluorescent probes
Thioester intermediate formation: Detect the acyl-enzyme intermediate by mass spectrometry
Substrate binding: Confirm interaction with lipopeptide substrates like FSL-1
Complete catalytic cycle: Demonstrate full N-acyltransferase activity
Comparative benchmarking:
Compare spectroscopic properties with well-characterized membrane proteins
Benchmark activity against native Lnt when available
Correlate structural parameters with functional outcomes
This comprehensive assessment provides confidence in the structural integrity and catalytic functionality of the recombinant Lnt protein.
Distinguishing between expression limitations and detection issues requires targeted experimental approaches:
Expression level assessment:
Quantitative western blotting: Compare recombinant Lnt levels to known standards using anti-His or anti-V5 antibodies
Fluorescent fusion reporters: Create GFP fusions to directly visualize expression levels
mRNA quantification: Measure transcript levels using RT-qPCR
Pulse-chase labeling: Determine protein synthesis and turnover rates
Detection sensitivity evaluation:
Limit of detection determination: Establish minimum detectable enzyme concentration
Signal amplification methods: Implement coupled enzyme assays to enhance sensitivity
Alternative detection technologies: Compare radioactive, fluorescent, and mass spectrometry approaches
Substrate concentration optimization: Ensure substrate levels are appropriate for detection
Distinguishing experimental matrix:
| Observation | Expression Limitation | Detection Limitation | Distinguishing Test |
|---|---|---|---|
| No activity detected | Insufficient protein expressed | Activity below detection threshold | Concentrate protein and retest |
| Inconsistent activity | Variable expression levels | Variable assay performance | Normalize activity to protein amount |
| Activity not proportional to protein | Inactive protein fraction | Non-linear detection range | Verify detection system linearity |
| Substrate-dependent activity loss | Substrate inhibition | Substrate interference with detection | Vary substrate presentation method |
Optimization strategies:
For confirmed expression limitations:
For confirmed detection limitations:
This systematic approach allows researchers to accurately identify and address the true limiting factors in their experimental system.